Latest news
The Difference the New ADHD Drug Named Simtriyo Makes and How It Works in the Brain - inklinkl · Fri, 07 Aug 2026 07:00:00 GMTCentanafadine Gains FDA Approval for ADHD Across Age Groups - Patient Care OnlinePatient Care Online · Wed, 05 Aug 2026 15:24:22 GMTAPAC Healthcare Weekly (August 2) – CSPC, Hengrui, Otsuka, Nippon Shinyaku, PharmaEssnetia, Cipla - SmartkarmaSmartkarma · Sun, 02 Aug 2026 01:43:09 GMTA New Mechanism for ADHD: Raman Baweja, MD, on Centanafadine's FDA Approval - Psychiatric TimesPsychiatric Times · Fri, 31 Jul 2026 07:00:00 GMTFierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod - Fierce PharmaFierce Pharma · Fri, 31 Jul 2026 07:00:00 GMTFDA approval of Simtriyo gives ADHD prescribers a new option—and new safety questions - MDLinxMDLinx · Thu, 30 Jul 2026 13:58:55 GMTADHD: FDA Approves New CNS Drug Simtriyo for Adults and Children - healthline.comhealthline.com · Wed, 29 Jul 2026 07:00:00 GMTCentanafadine Receives FDA Approval for the Treatment of ADHD - ADDitudeADDitude · Wed, 29 Jul 2026 07:00:00 GMT